Adlai Nortye ANL
NASDAQ ANL
$9.96 -1.19 (-10.67%)
At close: Nov 10, 2026 · 4:00 PM EST

Adlai Nortye (ANL) Receivables - Other (2022 - 2025)

Updated

Adlai Nortye (ANL) posted Receivables - Other of $907,000 for Q4 2025, up 262.8% from $250,000 a year earlier.

Analysis

Adlai Nortye (ANL) Receivables - Other (2022 - 2025) Analysis & Trends

Since Q4 2022, Adlai Nortye has reported Receivables - Other for 4 quarters.

  • Annual Receivables - Other shows a three-year compound annual growth rate of -80.1% (FY2022 to FY2025).
  • In prior years, Adlai Nortye's Receivables - Other was $250,000 in FY2024 (+11.6%), $224,000 in FY2023 (-99.8%) and $115.74 million in FY2022.
  • The Q4 2025 figure stands as the highest quarterly Receivables - Other since Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Adlai Nortye 342.45 Mn 139.24 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 907,000.00
Dec 31, 2024 250,000.00
Dec 31, 2023 224,000.00
Dec 31, 2022 115.74 Mn
API Access

Adlai Nortye Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=ANL&period=max&api_key=YOUR_API_KEY